Intrexon | XON - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Agenus USD 3.46M 6.08M 2025-09
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.48M 509K 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
MannKind USD 74.88M 52.51M 2025-12
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veracyte USD 362.58M 47M 2025-12
Xencor USD 54.07M 25.78M 2025-12